Last reviewed · How we verify

NCT05811221

Application of Different Modes of Esketamine Administration in Pediatric Day Circumcision

Status unknown NA Last updated 13 April 2023
What this trial tests

NA trial testing Esketamine of single injection in Pain in 70 participants. Status unknown.

Timeline
2 April 2023
Primary endpoint
15 May 2023
1 June 2023

Quick facts

Lead sponsorYangzhou University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeother
Enrollment70
Start date2 April 2023
Primary completion15 May 2023
Estimated completion1 June 2023

Drugs / interventions tested

Conditions studied

Sponsor

Yangzhou University

Who can join

Adults 6 to 12, male only, with Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To explore the application of different administration modes of esketamine in pediatric day circumcision, in order to find an anesthesia scheme more suitable for day pediatric circumcision.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pain

Currently open trials in the same condition.

Other Yangzhou University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05811221.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing